Chiesi Group is taking KalVista Pharmaceuticals under its wing, paying $1.9 billion for the biotech’s oral therapy Ekterly to ...

By Mariam Sunny April 29 (Reuters) - Biogen beat first-quarter expectations on Wednesday, as stronger sales of its ...

Hannah Strickland is only 9 years old, but her big personality is capturing hearts online. Whether she's describing her ramen ...

Astellas Pharma has done some spring cleaning of its pipeline, dropping two phase 1 candidates and slamming the brakes on a ...

As Ekterly nears the one-year anniversary of its FDA approval, Italy’s Chiesi Group is making moves to acquire the rare ...

Jessika Barcynski, from Farsley, is raising money for her Leigh's Syndrome research.

Lozano is a rare disease mom, neuroscience Ph.D. candidate at UC Davis, and board member for the PURA Syndrome Foundation. In May, a historic moment in science and medicine was captured in a single ...

Chiesi Group (“Chiesi”), an international research-focused biopharmaceutical group and certified B Corp, and KalVista Pharmaceuticals, Inc. (“KalVista”) (Nasdaq: KALV), today announced that the ...

Rare diseases, defined as conditions that affect a small percentage of the population, represent a significant challenge in medical research and healthcare. Collectively, these diseases encompass a ...

Support is growing for an Ocean County father and longtime healthcare worker battling a rare autoimmune disease, according to ...

Our inbox has been flooded with emails from viewers and readers who told us how their lives have been affected by rare diseases. Here are some of the stories we received. Living with a rare disease ...

Actor Kwon Oh-joong shed tears while recounting his son’s experience of school violence amid a rare genetic disorder. On the ...